Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2021

Open Access 01-12-2021 | Heart Failure | Research article

Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study

Authors: Zhaojie Dong, Xin Du, Shangxin Lu, Chao Jiang, Shijun Xia, Liu He, Xin Su, Zhaoxu Jia, Deyong Long, Caihua Sang, Ribo Tang, Nian Liu, Rong Bai, Ronghui Yu, Jianzeng Dong, Changsheng Ma

Published in: BMC Cardiovascular Disorders | Issue 1/2021

Login to get access

Abstract

Background

Patients with atrial fibrillation (AF) underwent a high risk of hospitalization, which has not been paid much attention to in practice. Therefore, we aimed to assess the incidence, causes and predictors of hospitalization in AF patients.

Methods

From August 2011 to December 2017, a total number of 20,172 AF patients from the Chinese Atrial Fibrillation Registry (China-AF) Study were prospectively selected for this study. We described the incidence, causes of hospitalization by age groups and sex. The Fine-Gray competing risk model was employed to identify predictors of first all-cause and first cause-specific hospitalization.

Results

After a mean follow-up of 37.3 ± 20.4 months, 7,512 (37.2%) AF patients experienced one or more hospitalizations. The overall incidence of all-cause hospitalization was 24.0 per 100 patient-years. Patients aged < 65 years were predominantly hospitalized for AF (42.1% of the total hospitalizations); while patients aged 65–74 and ≥ 75 years were mainly hospitalized for non-cardiovascular diseases (43.6% and 49.3%, respectively). We found patients complicated with heart failure (HF)[hazard ratio (HR) 1.10, 95% confidence interval (CI) 1.02–1.18], established coronary artery disease (CAD) (HR 1.24, 95%CI 1.17–1.33), ischemic stroke/transient ischemic attack (TIA) (HR 1.22, 95%CI 1.15–1.30), diabetes (HR 1.14, 95%CI 1.08–1.20), chronic obstructive pulmonary disease (COPD) (HR 1.28, 95%CI 1.02–1.62), gastrointestinal disorder (HR 1.37, 95%CI 1.21–1.55), and renal dysfunction (HR 1.24, 95%CI 1.09–1.42) had higher risks of hospitalization.

Conclusions

More than one-third of AF patients included in this study were hospitalized at least once during over 3-year follow-up. The main cause for hospitalization among the elderly patients (≥ 65 years) is non-cardiovascular diseases rather than AF. Multidisciplinary management of comorbidities should be advocated to reduce hospitalization in AF patients older than 65 years old.
Clinical Registryhttp://​www.​chictr.​org.​cn/​showproj.​aspx?​proj=​5831. Unique identifier: ChiCTR-OCH-13003729. The registration date is October 22, 2013.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.CrossRef Chugh SS, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin EJ, Gillum RF, Kim YH, McAnulty JH Jr, Zheng ZJ, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837–47.CrossRef
2.
go back to reference Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart. 2010;96(23):1878–82.CrossRef Sliwa K, Carrington MJ, Klug E, Opie L, Lee G, Ball J, Stewart S. Predisposing factors and incidence of newly diagnosed atrial fibrillation in an urban African community: insights from the Heart of Soweto Study. Heart. 2010;96(23):1878–82.CrossRef
3.
go back to reference Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust. 2015;202(1):32–5.CrossRef Ball J, Thompson DR, Ski CF, Carrington MJ, Gerber T, Stewart S. Estimating the current and future prevalence of atrial fibrillation in the Australian adult population. Med J Aust. 2015;202(1):32–5.CrossRef
4.
go back to reference Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–8.CrossRef Björck S, Palaszewski B, Friberg L, Bergfeldt L. Atrial fibrillation, stroke risk, and warfarin therapy revisited: a population-based study. Stroke. 2013;44(11):3103–8.CrossRef
5.
go back to reference Dudink E, Erküner Ö, Berg J, Nieuwlaat R, de Vos CB, Weijs B, Capucci A, Camm AJ, Breithardt G, Le Heuzey JY, et al. The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace. 2018;20(6):929–34.CrossRef Dudink E, Erküner Ö, Berg J, Nieuwlaat R, de Vos CB, Weijs B, Capucci A, Camm AJ, Breithardt G, Le Heuzey JY, et al. The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. Europace. 2018;20(6):929–34.CrossRef
6.
go back to reference Adderley NJ, Nirantharakumar K, Marshall T. Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies. BMJ. 2018;361:k1717.PubMedPubMedCentral Adderley NJ, Nirantharakumar K, Marshall T. Risk of stroke and transient ischaemic attack in patients with a diagnosis of resolved atrial fibrillation: retrospective cohort studies. BMJ. 2018;361:k1717.PubMedPubMedCentral
7.
go back to reference Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555–66.CrossRef Ruddox V, Sandven I, Munkhaugen J, Skattebu J, Edvardsen T, Otterstad JE. Atrial fibrillation and the risk for myocardial infarction, all-cause mortality and heart failure: A systematic review and meta-analysis. Eur J Prev Cardiol. 2017;24(14):1555–66.CrossRef
8.
go back to reference Christiansen CB, Olesen JB, Gislason G, Lock-Hansen M, Torp-Pedersen C: Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study. BMJ Open. 2013, 3:1. Christiansen CB, Olesen JB, Gislason G, Lock-Hansen M, Torp-Pedersen C: Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study. BMJ Open. 2013, 3:1.
9.
go back to reference Gallagher C, Hendriks JM, Giles L, Karnon J, Pham C, Elliott AD, Middeldorp ME, Mahajan R, Lau DH, Sanders P, et al. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart. 2019;105(17):1358–63.CrossRef Gallagher C, Hendriks JM, Giles L, Karnon J, Pham C, Elliott AD, Middeldorp ME, Mahajan R, Lau DH, Sanders P, et al. Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013. Heart. 2019;105(17):1358–63.CrossRef
10.
go back to reference Kim D, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, et al. Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. Heart. 2018;104(24):2010–7.CrossRef Kim D, Yang PS, Jang E, Yu HT, Kim TH, Uhm JS, Kim JY, Pak HN, Lee MH, Joung B, et al. Increasing trends in hospital care burden of atrial fibrillation in Korea, 2006 through 2015. Heart. 2018;104(24):2010–7.CrossRef
11.
go back to reference Wang X, Fu Q, Song F, Li W, Yin X, Yue W, Yan F, Zhang H, Zhang H, Teng Z, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey. Int J Cardiol. 2018;271:92–7.CrossRef Wang X, Fu Q, Song F, Li W, Yin X, Yue W, Yan F, Zhang H, Zhang H, Teng Z, et al. Prevalence of atrial fibrillation in different socioeconomic regions of China and its association with stroke: Results from a national stroke screening survey. Int J Cardiol. 2018;271:92–7.CrossRef
12.
go back to reference Du X, Ma C, Wu J, Li S, Ning M, Tang R, Guo X, Long D, Yu R, Sang C, et al. Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC Cardiovasc Disord. 2016;16:130.CrossRef Du X, Ma C, Wu J, Li S, Ning M, Tang R, Guo X, Long D, Yu R, Sang C, et al. Rationale and design of the Chinese Atrial Fibrillation Registry Study. BMC Cardiovasc Disord. 2016;16:130.CrossRef
13.
go back to reference Steinberg BA, Kim S, Fonarow GC, Thomas L, Ansell J, Kowey PR, Mahaffey KW, Gersh BJ, Hylek E, Naccarelli G, et al. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014;167(5):735-742.e2.CrossRef Steinberg BA, Kim S, Fonarow GC, Thomas L, Ansell J, Kowey PR, Mahaffey KW, Gersh BJ, Hylek E, Naccarelli G, et al. Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF). Am Heart J. 2014;167(5):735-742.e2.CrossRef
14.
go back to reference Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, et al. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Heart J. 2014;35(47):3365–76.CrossRef Lip GY, Laroche C, Ioachim PM, Rasmussen LH, Vitali-Serdoz L, Petrescu L, Darabantiu D, Crijns HJ, Kirchhof P, Vardas P, et al. Prognosis and treatment of atrial fibrillation patients by European cardiologists: one year follow-up of the EURObservational Research Programme-Atrial Fibrillation General Registry Pilot Phase (EORP-AF Pilot registry). Eur Heart J. 2014;35(47):3365–76.CrossRef
15.
go back to reference Chamberlain AM, Alonso A, Gersh BJ, Manemann SM, Killian JM, Weston SA, Byrne M, Roger VL. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study. Am Heart J. 2017;185:74–84.CrossRef Chamberlain AM, Alonso A, Gersh BJ, Manemann SM, Killian JM, Weston SA, Byrne M, Roger VL. Multimorbidity and the risk of hospitalization and death in atrial fibrillation: a population-based study. Am Heart J. 2017;185:74–84.CrossRef
16.
go back to reference van Doorn S, Tavenier A, Rutten FH, Hoes AW, Moons K, Geersing GJ. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands. BMJ Open. 2018;8(8):e021681.CrossRef van Doorn S, Tavenier A, Rutten FH, Hoes AW, Moons K, Geersing GJ. Risk of cardiac and non-cardiac adverse events in community-dwelling older patients with atrial fibrillation: a prospective cohort study in the Netherlands. BMJ Open. 2018;8(8):e021681.CrossRef
17.
go back to reference DeVore AD, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, et al. Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF. Europace. 2016;18(8):1135–42.CrossRef DeVore AD, Hellkamp AS, Becker RC, Berkowitz SD, Breithardt G, Hacke W, Halperin JL, Hankey GJ, Mahaffey KW, Nessel CC, et al. Hospitalizations in patients with atrial fibrillation: an analysis from ROCKET AF. Europace. 2016;18(8):1135–42.CrossRef
18.
go back to reference Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, et al. Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry. J Am Coll Cardiol. 2016;68(24):2597–604.CrossRef Steinberg BA, Shrader P, Thomas L, Ansell J, Fonarow GC, Gersh BJ, Kowey PR, Mahaffey KW, Naccarelli G, Reiffel J, et al. Off-label dosing of non-vitamin K antagonist oral anticoagulants and adverse outcomes: the ORBIT-AF II registry. J Am Coll Cardiol. 2016;68(24):2597–604.CrossRef
19.
go back to reference Ballı M, Taşolar H, Çetin M, Hatem E, Çağlıyan ÇE, Şeker T, Çaylı M. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction. J Cardiol. 2016;67(4):327–30.CrossRef Ballı M, Taşolar H, Çetin M, Hatem E, Çağlıyan ÇE, Şeker T, Çaylı M. Is atrial fibrillation a risk factor for contrast-induced nephropathy in patients with ST-elevation myocardial infarction. J Cardiol. 2016;67(4):327–30.CrossRef
20.
go back to reference Rewiuk K, Wizner B, Klich-Rączka A, Więcek A, Mossakowska M, Chudek J, Szybalska A, Broczek K, Zdrojewski T, Grodzicki T: Atrial fibrillation independently linked with depression in community-dwelling older population. Results from the nationwide PolSenior project. Exp Gerontol 2018, 112:88–91. Rewiuk K, Wizner B, Klich-Rączka A, Więcek A, Mossakowska M, Chudek J, Szybalska A, Broczek K, Zdrojewski T, Grodzicki T: Atrial fibrillation independently linked with depression in community-dwelling older population. Results from the nationwide PolSenior project. Exp Gerontol 2018, 112:88–91.
21.
go back to reference Hung CS, Chang CH, Lin JW, Ho YL, Chen MF. The association between new onset atrial fibrillation and incident cancer-A nationwide cohort study. PLoS ONE. 2018;13(6):e0199901.CrossRef Hung CS, Chang CH, Lin JW, Ho YL, Chen MF. The association between new onset atrial fibrillation and incident cancer-A nationwide cohort study. PLoS ONE. 2018;13(6):e0199901.CrossRef
22.
go back to reference Al-Shammari B, Khalifa M, Bakheet SA, Yasser M. A mechanistic study on the amiodarone-induced pulmonary toxicity. Oxid Med Cell Longev. 2016;2016:6265853.CrossRef Al-Shammari B, Khalifa M, Bakheet SA, Yasser M. A mechanistic study on the amiodarone-induced pulmonary toxicity. Oxid Med Cell Longev. 2016;2016:6265853.CrossRef
23.
go back to reference Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox K, Goto S, Haas S, Hacke W, Kayani G, et al. Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation. Circulation. 2019;139(6):787–98.CrossRef Bassand JP, Virdone S, Goldhaber SZ, Camm AJ, Fitzmaurice DA, Fox K, Goto S, Haas S, Hacke W, Kayani G, et al. Early risks of death, stroke/systemic embolism, and major bleeding in patients with newly diagnosed atrial fibrillation. Circulation. 2019;139(6):787–98.CrossRef
24.
go back to reference Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7(2):55–66.CrossRef Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. European thyroid association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018;7(2):55–66.CrossRef
25.
go back to reference Li YM, Jiang C, He L, Li XX, Hou XX, Chang SS, Lip G, Du X, Dong JZ, Ma CS. Sex differences in presentation, quality of life, and treatment in Chinese atrial fibrillation patients: insights from the china atrial fibrillation registry study. Med Sci Monit. 2019;25:8011–8.CrossRef Li YM, Jiang C, He L, Li XX, Hou XX, Chang SS, Lip G, Du X, Dong JZ, Ma CS. Sex differences in presentation, quality of life, and treatment in Chinese atrial fibrillation patients: insights from the china atrial fibrillation registry study. Med Sci Monit. 2019;25:8011–8.CrossRef
26.
go back to reference Chapa DW, Akintade B, Thomas SA, Friedmann E. Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: a systematic review. Heart Lung. 2015;44(3):189–98.CrossRef Chapa DW, Akintade B, Thomas SA, Friedmann E. Gender differences in stroke, mortality, and hospitalization among patients with atrial fibrillation: a systematic review. Heart Lung. 2015;44(3):189–98.CrossRef
27.
go back to reference Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, et al. Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015;8(4):393–402.CrossRef Freeman JV, Simon DN, Go AS, Spertus J, Fonarow GC, Gersh BJ, Hylek EM, Kowey PR, Mahaffey KW, Thomas LE, et al. Association between atrial fibrillation symptoms, quality of life, and patient outcomes: results from the outcomes registry for better informed treatment of atrial fibrillation (ORBIT-AF). Circ Cardiovasc Qual Outcomes. 2015;8(4):393–402.CrossRef
28.
go back to reference Vermond RA, Crijns HJ, Tijssen JG, Alings AM, Van den Berg MP, Hillege HL, Van Veldhuisen DJ, Van Gelder IC, Rienstra M. RACE II investigators: symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study. Europace. 2014;16(10):1417–25.CrossRef Vermond RA, Crijns HJ, Tijssen JG, Alings AM, Van den Berg MP, Hillege HL, Van Veldhuisen DJ, Van Gelder IC, Rienstra M. RACE II investigators: symptom severity is associated with cardiovascular outcome in patients with permanent atrial fibrillation in the RACE II study. Europace. 2014;16(10):1417–25.CrossRef
29.
go back to reference Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kennebäck G, Rubulis A, Malmborg H, Raatikainen P, Lönnerholm S, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. JAMA. 2019;321(11):1059–68.CrossRef Blomström-Lundqvist C, Gizurarson S, Schwieler J, Jensen SM, Bergfeldt L, Kennebäck G, Rubulis A, Malmborg H, Raatikainen P, Lönnerholm S, et al. Effect of catheter ablation vs antiarrhythmic medication on quality of life in patients with atrial fibrillation: the CAPTAF randomized clinical trial. JAMA. 2019;321(11):1059–68.CrossRef
30.
go back to reference Guo J, Nayak HM, Besser SA, Beaser A, Aziz Z, Broman M, Ozcan C, Tung R, Upadhyay GA. Impact of atrial fibrillation ablation on recurrent hospitalization: a nationwide cohort study. JACC Clin Electrophysiol. 2019;5(3):330–9.CrossRef Guo J, Nayak HM, Besser SA, Beaser A, Aziz Z, Broman M, Ozcan C, Tung R, Upadhyay GA. Impact of atrial fibrillation ablation on recurrent hospitalization: a nationwide cohort study. JACC Clin Electrophysiol. 2019;5(3):330–9.CrossRef
31.
go back to reference Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–92.CrossRef Santhanakrishnan R, Wang N, Larson MG, Magnani JW, McManus DD, Lubitz SA, Ellinor PT, Cheng S, Vasan RS, Lee DS, et al. Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction. Circulation. 2016;133(5):484–92.CrossRef
32.
go back to reference Violi F, Soliman EZ, Pignatelli P, Pastori D: Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc 2016, 5(5). Violi F, Soliman EZ, Pignatelli P, Pastori D: Atrial fibrillation and myocardial infarction: a systematic review and appraisal of pathophysiologic mechanisms. J Am Heart Assoc 2016, 5(5).
33.
go back to reference Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62.CrossRef Schnabel RB, Yin X, Gona P, Larson MG, Beiser AS, McManus DD, Newton-Cheh C, Lubitz SA, Magnani JW, Ellinor PT, et al. 50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in the Framingham Heart Study: a cohort study. Lancet. 2015;386(9989):154–62.CrossRef
34.
go back to reference Özlek B, Özlek E, Tekinalp M, Kahraman S, Zencirkiran Agus H, Başaran Ö, Kaya BC, Rencüzoğulları İ, Mert KU, Çakır O, et al. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry. Turk Kardiyol Dern Ars. 2020;48(3):234–45.PubMed Özlek B, Özlek E, Tekinalp M, Kahraman S, Zencirkiran Agus H, Başaran Ö, Kaya BC, Rencüzoğulları İ, Mert KU, Çakır O, et al. Comparison of clinical characteristics of patients with heart failure and preserved ejection fraction with atrial fibrillation versus sinus rhythm: Insights from the APOLLON registry. Turk Kardiyol Dern Ars. 2020;48(3):234–45.PubMed
35.
go back to reference Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRef Gansevoort RT, Correa-Rotter R, Hemmelgarn BR, Jafar TH, Heerspink HJ, Mann JF, Matsushita K, Wen CP. Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention. Lancet. 2013;382(9889):339–52.CrossRef
36.
go back to reference Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367(7):625–35.CrossRef Olesen JB, Lip GY, Kamper AL, Hommel K, Køber L, Lane DA, Lindhardsen J, Gislason GH, Torp-Pedersen C. Stroke and bleeding in atrial fibrillation with chronic kidney disease. N Engl J Med. 2012;367(7):625–35.CrossRef
37.
go back to reference Becattini C, Giustozzi M, Ranalli MG, Bogliari G, Cianella F, Verso M, Agnelli G, Vedovati MC. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation. J Thromb Haemost. 2018;16(5):833–41.CrossRef Becattini C, Giustozzi M, Ranalli MG, Bogliari G, Cianella F, Verso M, Agnelli G, Vedovati MC. Variation of renal function over time is associated with major bleeding in patients treated with direct oral anticoagulants for atrial fibrillation. J Thromb Haemost. 2018;16(5):833–41.CrossRef
38.
go back to reference Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND. Risk of gastrointestinal bleeding increases with combinations of antithrombotic agents and patient age. Clin Gastroenterol Hepatol. 2020;18(2):337-346.e19.CrossRef Abraham NS, Noseworthy PA, Inselman J, Herrin J, Yao X, Sangaralingham LR, Cornish G, Ngufor C, Shah ND. Risk of gastrointestinal bleeding increases with combinations of antithrombotic agents and patient age. Clin Gastroenterol Hepatol. 2020;18(2):337-346.e19.CrossRef
39.
go back to reference Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study. PLoS ONE. 2013;8(2):e56944.CrossRef Kristensen SL, Ahlehoff O, Lindhardsen J, Erichsen R, Jensen GV, Torp-Pedersen C, Nielsen OH, Gislason GH, Hansen PR. Disease activity in inflammatory bowel disease is associated with increased risk of myocardial infarction, stroke and cardiovascular death–a Danish nationwide cohort study. PLoS ONE. 2013;8(2):e56944.CrossRef
40.
go back to reference Thorne K, Jayathissa S, Dee S, Briggs N, Taylor J, Reid S, De Silva K, Dean J. Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice. Intern Med J. 2014;44(3):261–5.CrossRef Thorne K, Jayathissa S, Dee S, Briggs N, Taylor J, Reid S, De Silva K, Dean J. Adherence and outcomes of patients prescribed dabigatran (Pradaxa) in routine clinical practice. Intern Med J. 2014;44(3):261–5.CrossRef
41.
go back to reference Tangkiatkumjai M, Walker DM, Praditpornsilpa K, Boardman H. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol. 2017;21(3):504–12.CrossRef Tangkiatkumjai M, Walker DM, Praditpornsilpa K, Boardman H. Association between medication adherence and clinical outcomes in patients with chronic kidney disease: a prospective cohort study. Clin Exp Nephrol. 2017;21(3):504–12.CrossRef
Metadata
Title
Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
Authors
Zhaojie Dong
Xin Du
Shangxin Lu
Chao Jiang
Shijun Xia
Liu He
Xin Su
Zhaoxu Jia
Deyong Long
Caihua Sang
Ribo Tang
Nian Liu
Rong Bai
Ronghui Yu
Jianzeng Dong
Changsheng Ma
Publication date
01-12-2021
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2021
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-021-01951-5

Other articles of this Issue 1/2021

BMC Cardiovascular Disorders 1/2021 Go to the issue